125 related articles for article (PubMed ID: 15602112)
1. The 5-HT1D receptor agonist zolmitriptan for neuroleptic-induced akathisia: an open label preliminary study.
Gross-Isseroff R; Magen A; Shiloh R; Hermesh H; Weizman A
Int Clin Psychopharmacol; 2005 Jan; 20(1):23-5. PubMed ID: 15602112
[TBL] [Abstract][Full Text] [Related]
2. Zolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study.
Avital A; Gross-Isseroff R; Stryjer R; Hermesh H; Weizman A; Shiloh R
Eur Neuropsychopharmacol; 2009 Jul; 19(7):476-82. PubMed ID: 19342206
[TBL] [Abstract][Full Text] [Related]
3. Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study.
Lerner V; Bergman J; Statsenko N; Miodownik C
J Clin Psychiatry; 2004 Nov; 65(11):1550-4. PubMed ID: 15554771
[TBL] [Abstract][Full Text] [Related]
4. Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study.
Miodownik C; Lerner V; Statsenko N; Dwolatzky T; Nemets B; Berzak E; Bergman J
Clin Neuropharmacol; 2006; 29(2):68-72. PubMed ID: 16614537
[TBL] [Abstract][Full Text] [Related]
5. Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study.
Stryjer R; Rosenzcwaig S; Bar F; Ulman AM; Weizman A; Spivak B
Clin Neuropharmacol; 2010; 33(5):219-22. PubMed ID: 20838215
[TBL] [Abstract][Full Text] [Related]
6. Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study.
Fischel T; Hermesh H; Aizenberg D; Zemishlany Z; Munitz H; Benjamini Y; Weizman A
J Clin Psychopharmacol; 2001 Dec; 21(6):612-5. PubMed ID: 11763011
[TBL] [Abstract][Full Text] [Related]
7. Lack of efficacy of the 5-HT3 receptor antagonist granisetron in the treatment of acute neuroleptic-induced akathisia.
Poyurovsky M; Weizman A
Int Clin Psychopharmacol; 1999 Nov; 14(6):357-60. PubMed ID: 10565803
[TBL] [Abstract][Full Text] [Related]
8. Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial.
Loder E; Freitag FG; Adelman J; Pearlmand S; Abu-Shakra S
Curr Med Res Opin; 2005 Mar; 21(3):381-9. PubMed ID: 15811207
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study.
Poyurovsky M; Epshtein S; Fuchs C; Schneidman M; Weizman R; Weizman A
J Clin Psychopharmacol; 2003 Jun; 23(3):305-8. PubMed ID: 12826992
[TBL] [Abstract][Full Text] [Related]
10. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
[TBL] [Abstract][Full Text] [Related]
11. Cyproheptadine treatment in neuroleptic-induced akathisia.
Weiss D; Aizenberg D; Hermesh H; Zemishlany Z; Munitz H; Radwan M; Weizman A
Br J Psychiatry; 1995 Oct; 167(4):483-6. PubMed ID: 8829717
[TBL] [Abstract][Full Text] [Related]
12. Review of zolmitriptan and its clinical applications in migraine.
Dowson AJ; Charlesworth B
Expert Opin Pharmacother; 2002 Jul; 3(7):993-1005. PubMed ID: 12083998
[TBL] [Abstract][Full Text] [Related]
13. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
[TBL] [Abstract][Full Text] [Related]
14. Propranolol in the treatment of neuroleptic-induced akathisia (NIA) in schizophrenics: a double-blind, placebo-controlled study.
Kramer MS; Gorkin RA; DiJohnson C; Sheves P
Biol Psychiatry; 1988 Nov; 24(7):823-7. PubMed ID: 2906547
[No Abstract] [Full Text] [Related]
15. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
Rothner AD; Wasiewski W; Winner P; Lewis D; Stankowski J
Headache; 2006 Jan; 46(1):101-9. PubMed ID: 16412157
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
Tuchman M; Hee A; Emeribe U; Silberstein S
CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
[TBL] [Abstract][Full Text] [Related]
17. Serotonergic agents in the treatment of acute neuroleptic-induced akathisia: open-label study of buspirone and mianserin.
Poyurovsky M; Weizman A
Int Clin Psychopharmacol; 1997 Sep; 12(5):263-8. PubMed ID: 9466160
[TBL] [Abstract][Full Text] [Related]
18. Actometry and Barnes Akathisia Rating Scale in neuroleptic-induced akathisia.
Janno S; Holi MM; Tuisku K; Wahlbeck K
Eur Neuropsychopharmacol; 2005 Jan; 15(1):39-41. PubMed ID: 15572272
[TBL] [Abstract][Full Text] [Related]
19. Part II: clinical efficacy and tolerability of zolmitriptan orally disintegrating tablet in the acute treatment of migraine.
Loder EW; Dowson AJ; Spierings EL
Curr Med Res Opin; 2005; 21 Suppl 3():S8-12. PubMed ID: 16083518
[TBL] [Abstract][Full Text] [Related]
20. Treatment of neuroleptic-induced akathisia with propranolol: a controlled replication study.
Kramer MS; Gorkin R; DiJohnson C
Hillside J Clin Psychiatry; 1989; 11(2):107-19. PubMed ID: 2577308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
